Vaccine prophylaxis of tuberculosis in the Metropolis: Its Efficiency and Emerging Issues
https://doi.org/10.31631/2073-3046-2016-15-3-49-59
Abstract
For example, a megacity of 10 years and an analysis of the problems, specific prevention of tuberculosis. Mass vaccination against tuberculosis leads to a reduction in morbidity and mortality from the disease according to Moscow. The main problems of vaccine prevention of tuberculosis in Moscow are to reduce vaccination coverage of newborns due to increased number of failures parents. The frequency of severe complications (BCG osteitis) was 0,004%, frequency of pulmonary complications - 0,005% (lymphadenitis), 0,01% (cold abscesses) to 100 thousand vaccinated. Possible complications of vaccine-B are not an occasion to review the policy on primary vaccination with BCG.
About the Authors
T. A. Sevostyanova
Moscow City Scientific and Practical Center of Tuberculosis
Russian Federation
Russian Federation
V. A. Aksenova
НИИ фтизиопульмонологии Первого МГМУ им. И.М. Сеченова
Russian Federation
Russian Federation
E. M. Belilovsky
Moscow City Scientific and Practical Center of Tuberculosis
Russian Federation
Russian Federation
References
1. European Centre for Disease Prevention and Control/WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2013. Stockholm, European Centre for Disease Prevention and Control. 2013.
2. Blasi F., Reichman L.B., Migliori G.B. Presenting the European Forum for TB Innovation: innovative thinking in progressing towards TB elimination in Europe. Eur. Respir. J. 2012; 40: 806 – 808.
3. Veen J., Migliori G.B., Raviglione M., Rieder H.L., Dara M., Falzon D. et al. Harmonisation of TB control in the WHO European region: the history of the Wolfheze Workshops. Eur. Respir. J. 2011; 37: 950 – 959.
4. Aksenovа V.A. Modern approaches to the use of anti-TB vaccination. Epidemiology and Vaccinal Prevention. 2004; 4: 13 – 16 (in Russian).
5. Sevostyanova T.A., Aksenovа V.A., Levi D.T. Problems of modern vaccine prophylaxis of tuberculosis in Russia. Proceedings of the 1st Congress of the National Association of TB specialists. St. Petersburg. 2012: 197 – 199 (in Russian).
6. Vasilyeva E.B., Fomina A.V., Сlinical and epidemiological characteristics of tuberculosis in young children. Probl. tub. 2008; 11: 24 – 27 (in Russian).
7. Levi D.T., Aleksandrova N.V., Ruhamina M.L., Podlipaeva I.V. Complications of BCG vaccination. All-Russian scientific-practical conference «Vaccinology 2010.
8. Improving immunobiologicheskih prevention, diagnosis and treatment of infectious diseases». Moscow. 2010: 67 – 68 (in Russian).
9. Raviglione M., Marais B., Floyd K., Lonnroth K., Getahun H., Migliori G.B. et al. Scaling up interventions to achieve global tuberculosis control: progress and new developments. Lancet. 2012; 379: 1902 – 1913.
10. Aksenovа V.A., Levi D.T. TB vaccine. Vaccines and vaccination. National leadership. 2011; 18: 371 – 412 (in Russian).
11. Trunz B.B., Fine P., Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet. 2006; 367: 1173 – 1180.
12. World Health Organization. BCG (Tuberculosis). Available at: www.who.int/biologicals/areas/vaccines/bcg/Tuberculosis/en/ Date last accessed: June 7, 2013. Date last updated: June 28, 2012.
13. Dara M., Acosta C.D., Rusovich V., Zellweger J.P., Centis R., Migliori G.B. WHO EURO Childhood Task Force Memb. Bacille Calmette-Guerin vaccination: the current situation in Europe. European Respiratory Journal. 2014; 43 (1): 24 – 35.
14. TB control in Moscow. An analytical review of statistics on tuberculosis, 2013. Ed.: Е.М. Bogorodskaya, V.I. Litvinov. Moscow. 2014: 15 (in Russian).
15. The Order of the Ministry of Health on March 21, 2014 № 125n «On approving the national calendar of preventive vaccinations and preventive vaccination calendar on epidemic indications» (in Russian).
16. Shamuratova L.F., Vlatskaya Y.F., Senchihina O.J., Sinitsyn M.V. Certain aspects of vaccine prevention of tuberculosis in children from prenatal exposure of HIV and their impact on the course of tuberculosis. Tuberculosis and socially significant morbidity. 2014; 5: 50 – 57 (in Russian).
17. Nuttall J.J.C., Eley B.S. BCG Vaccination in HIV-Infected Children. Tuberc. Res. Treat. 2011: 712 – 736.
18. Cuello-Garcı´a CA, Pe´rez-Gaxiola G, Jime´nez Gutie´rrez C. Treating BCG-induced disease in children. Cochrane Database Syst. Rev. 2013; 1: CD008300.
Review
For citations:
Sevostyanova T.A., Aksenova V.A., Belilovsky E.M. Vaccine prophylaxis of tuberculosis in the Metropolis: Its Efficiency and Emerging Issues. Epidemiology and Vaccinal Prevention. 2016;15(3):49-59. (In Russ.) https://doi.org/10.31631/2073-3046-2016-15-3-49-59
Views:
883
Email this article 